Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 19.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 54.00
  • 52 Week Low: 17.50
  • Currency: UK Pounds
  • Shares Issued: 194.59m
  • Volume: 73,070
  • Market Cap: £37.95m
  • Beta: 0.00

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -682.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 23.9 n/a
Pr/Book 2.1  
Latest F'cast
Revenue 43.4% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.79 (16.27) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

Ondine’s APDT reduces SARS-CoV-2 infectivity 31-Jan-2023 12:01 RNS
TR-1: Notification of major holdings 17-Jan-2023 10:04 RNS
Second Price Monitoring Extn 13-Jan-2023 16:40 RNS

OBI ShareCast News

Ondine Biomedical upbeat on photodisinfection st... 17-Jan-2023 ShareCast
Ondine reports success in MRSA clinical trial 02-Dec-2022 ShareCast
Ondine technology 'highly effective' against MRS... 19-Oct-2022 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 19.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 54.00
52 Week Low 17.50
Volume 73,070
Shares Issued 194.59m
Market Cap £37.95m
Beta 0.00

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.07% below the market average35.07% below the market average35.07% below the market average35.07% below the market average35.07% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average
Price Trend
60.06% below the market average60.06% below the market average60.06% below the market average60.06% below the market average60.06% below the market average
19.35% below the sector average19.35% below the sector average19.35% below the sector average19.35% below the sector average19.35% below the sector average
Income Not Available
Growth
8.17% above the market average8.17% above the market average8.17% above the market average8.17% above the market average8.17% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average

OBI Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
15:51 22,500 @ 19.50p
15:30 40,000 @ 19.49p
14:29 10,000 @ 19.47p
10:00 70 @ 19.89p
08:00 500 @ 20.00p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page